Application of MRI in Identifying Myelosuppression Risk of Neoadjuvant Chemoradiotherapy for Rectal Cancer

NCT04970498 · clinicaltrials.gov ↗

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer Stage II
Rectal Cancer Stage III

Interventions

DIAGNOSTIC_TEST: MRI
DIAGNOSTIC_TEST: blood routine test

Sponsor

Peking University Third Hospital